Modulation of Malignant Melanoma Growth with Vitamins and Other Chemically-Defined Biological Modifiers
- 1 January 1984
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Retinoids at the threshold: their biological significance and therapeutic potentialJournal of Medicinal Chemistry, 1982
- Identification of transformed glucocorticoid receptor from dexamethasone resistant melanomaThe Journal of Steroid Biochemistry and Molecular Biology, 1982
- Glucocorticoids and melanoma: Receptor properties of dexamethasone sensitive and resistant tumorsThe Journal of Steroid Biochemistry and Molecular Biology, 1982
- Thromboxanes and prostacyclin: Positive and negative modulators of tumor growthBiochemical and Biophysical Research Communications, 1981
- Modulation of abnormal growth by retinoids: A clinical perspective of the biological phenomenonLife Sciences, 1981
- 1,25-DIHYDROXYVITAMIN D3AND MALIGNANT MELANOMA: THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL GROWTH IN CULTUREEndocrinology, 1981
- Antitumor effects of vitamin A and inhibitors of ornithine decarboxylase in cultured neuroblastoma and glioma cellsLife Sciences, 1980
- Inhibition of prostaglandin biosynthesis by eicosapentaenoic acidProstaglandins and Medicine, 1979
- Inhibition of DNA synthesis in harding-passey melanoma cells by prostaglandins A1 and A2: Comparison with chemotherapeutic agentsBiochemical and Biophysical Research Communications, 1979
- Anti-proliferative properties of DL-α-difluoromethyl ornithine in cultured cells. A consequence of the irreversible inhibition of ornithine decarboxylaseBiochemical and Biophysical Research Communications, 1978